Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma. - Wikidata - awgldk - TriplyDB

Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma.

Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma.

http://www.wikidata.org/entity/Q53321450

about

Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas.DNA methylation in endometrial cancer KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics Clinical utility of RASSF1A methylation in human malignancies.Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer.The genomics and genetics of endometrial cancer.Methylation status and protein expression of RASSF1A in endometriosis The occurrence of fetal microchimeric cells in endometrial tissues is a very common phenomenon in benign uterine disorders, and the lower prevalence of fetal microchimerism is associated with better uterine cancer prognoses.Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism.Endometrial carcinoma: molecular alterations involved in tumor development and progression.Molecular pathology of endometrial carcinoma.Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.Endometrial Carcinoma: Specific Targeted Pathways.Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia.Systematic Analysis of Endometrial Cancer-Associated Hub Proteins Based on Text Mining Recent findings on epigenetic gene abnormalities involved in uterine cancer.Next-Generation Sequencing.RASSF1A and ERCC1 expression levels might be predictive of prognosis in advanced, recurrent, and metastatic squamous cell carcinoma of the head and neck treated with docetaxel and cisplatin.High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases.FGFR2 alterations in endometrial carcinoma

P2860

Q33718940-814AB644-CEB3-49B2-A64D-BCCE66BDFE71 Q33770920-E9EBDE3A-A5D2-4BB4-B2E3-E21AD803DEC0 Q34195371-E2DB4100-2CFE-4BA8-9C33-E30D1650EE6D Q34805471-9A949EC6-A44C-499C-BB70-E659E8274B14 Q35882785-32423BDA-E94D-4A4F-AA60-B27E9EB3D8CC Q35909621-CE01B859-BB82-4B27-A8FD-E0EA647D3141 Q35993546-298F0CBE-37DF-410D-9F88-32BB20256DDB Q36151896-C47CAF63-3DBC-4386-8CFD-EC23E4E17A00 Q36954256-F462BDF2-5A88-475D-AFCA-8BFC35DF5588 Q37433980-9B0EF32A-C70B-46F5-B9EF-83A7E97DE886 Q37588464-B8F190A6-476D-4D9D-8879-91F536208FE5 Q37994980-9E0AA75C-714A-41A7-9472-C5FAFE561138 Q38067440-14B90CD9-245C-484D-A766-1BA51246AD37 Q38240724-7199D2BE-8121-4058-8246-B1362A6BB39D Q38630962-E56CAEA1-6A7B-4F59-8381-5813D7F1191F Q38812830-57B7E8A8-6392-4F09-B310-0945878DF0FC Q39026766-1B5E6EFF-46EF-4AE3-BC62-B2B2322AF2FF Q39282288-C061E3D6-5888-461F-BF77-06BC733F1A0B Q39406462-C0187F31-ED54-4D9E-9C76-5D8607F2BF4F Q40543038-D9F17B80-3573-4639-9284-2ED7EFB26792 Q47153989-A2C8E9D2-F3DC-4EE3-A87B-03B658A94A03 Q51032285-2AB108FC-70D4-4C89-A61B-C63A06D8B8A4 Q53134485-669BA302-DD45-4835-8263-6210BAB4EF3E Q53249908-41DCBDC1-51F7-479F-8D14-227637BAE42A Q59123115-EC9912C6-671A-4939-AE95-F69247745686

P2860

Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma.

http://www.wikidata.org/entity/Q53321450

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Promoter hypermethylation and ...... ions of endometrial carcinoma.

@en

Promoter hypermethylation and ...... ions of endometrial carcinoma.

@nl

type

label

Promoter hypermethylation and ...... ions of endometrial carcinoma.

@en

Promoter hypermethylation and ...... ions of endometrial carcinoma.

@nl

prefLabel

Promoter hypermethylation and ...... ions of endometrial carcinoma.

@en

Promoter hypermethylation and ...... ions of endometrial carcinoma.

@nl

P1433

Q53321450-1876A304-18A9-4762-B52A-3332D342F9CC

P1476

Q53321450-ADA1D3FB-48A2-4566-95B0-909B91A2711F

P2093

Q53321450-113FED46-689D-49D6-8BC7-39EE6A54AF73

Q53321450-21FA04D2-87CF-4BC6-9806-6ACDFC85716C

Q53321450-28ABDC0D-A833-4463-BDE8-4721F4CCE66A

Q53321450-5994BCA3-B033-44E9-9514-795F1A869B66

Q53321450-6FBD2946-6E94-467C-AE73-F67CAAA3C58A

Q53321450-72425E63-E606-4BC5-99D6-7C3B716DBB26

Q53321450-8935025C-5AA6-4BD3-8677-FE9FE2968564

Q53321450-89C15BF4-C582-49AD-8373-02087CB94142

P2860

Q53321450-05013DD1-FF61-4455-85B6-910AD429E6D2

Q53321450-0CD88FCE-752E-47ED-A462-0588BFC57455

Q53321450-5FB0B7AF-D4CE-4F94-9198-9A2AFB52F384

Q53321450-6B66EBC6-2861-4DBB-A955-8181A9F7160D

Q53321450-72BD103C-CF14-4D0A-9C36-04F5436688C4

Q53321450-7E336526-1B03-442F-B3FA-C5D52BBEEF9F

Q53321450-8447BB61-969D-4862-AF74-A4FB9A873542

Q53321450-8F2CF4EF-F53D-4B13-AF61-FE71E1201FF5

Q53321450-8FF1F95F-4169-403E-99DE-07A75D92728E

Q53321450-945AC6F7-00A6-475E-BB02-A996631E2BC8

P2888

Q53321450-C9358916-A42A-41F8-B6EA-BE3D40588E1A

P304

Q53321450-BE40F917-7AAC-4A69-B326-A7E3CF5C8448

P31

Q53321450-6AA1311B-C8DB-49EB-A4FF-949FB2C41714

P356

Q53321450-1A53E258-1361-48E5-BC60-51DB67337064

P433

Q53321450-DC10C97C-CAC8-48EB-9B15-C6B129C13461

P478

Q53321450-9E33014E-C5D7-4268-8860-98B87E164023

P50

Q53321450-1EA63665-C1CE-43AF-94B4-5C21C867FDC7

Q53321450-ED37FAB1-9C55-49D9-A744-0F1B729C7EBC

P577

Q53321450-848F4FA6-DE23-4C85-9298-8CF271748344

P5875

Q53321450-5DC2B9F7-1998-442C-866E-21588C621092

P698

Q53321450-D0CE8B23-18BC-4718-BCFC-6C686030CBBF

P356

MODPATHOL.2008.38

P1433

Modern Pathology

P1476

Promoter hypermethylation and ...... tions of endometrial carcinoma

@en

P2093

Jaime Prat

http://www.w3.org/2001/XMLSchema#string

Judit Pallarés

http://www.w3.org/2001/XMLSchema#string

Lluis Catasús

http://www.w3.org/2001/XMLSchema#string

Miriam Cuatrecasas

http://www.w3.org/2001/XMLSchema#string

Nuria Eritja

http://www.w3.org/2001/XMLSchema#string

Victor Palomar-Asenjo

http://www.w3.org/2001/XMLSchema#string

Xavier Dolcet

http://www.w3.org/2001/XMLSchema#string

Xavier Matias-Guiu

http://www.w3.org/2001/XMLSchema#string

P2860

The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex

hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors

Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

Molecular pathology of endometrial hyperplasia and carcinoma.

Two pathogenetic types of endometrial carcinoma.

Cyclin A is a mediator of p120E4F-dependent cell cycle arrest in G1.

RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer.

P2888

modpathol.2008.38

P304

691-699

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2008.38

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Maria Santacana

P577

2008-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5381345

http://www.w3.org/2001/XMLSchema#string

P698

18469797

http://www.w3.org/2001/XMLSchema#string